News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
593,294 Results
Type
Article (42723)
Company Profile (319)
Press Release (550252)
Section
Business (167830)
Career Advice (2439)
Deals (30346)
Drug Delivery (106)
Drug Development (78690)
Employer Resources (148)
FDA (14384)
Job Trends (12986)
News (296155)
Policy (28515)
Tag
Academia (2660)
Alliances (42881)
Alzheimer's disease (1374)
Approvals (14354)
Artificial intelligence (202)
Bankruptcy (322)
Best Places to Work (10685)
Biotechnology (258)
Breast cancer (226)
Cancer (1723)
Cardiovascular disease (141)
Career advice (2046)
CAR-T (128)
Cell therapy (369)
Clinical research (63176)
Collaboration (657)
Compensation (272)
COVID-19 (2543)
C-suite (171)
Data (1626)
Diabetes (209)
Diagnostics (5757)
Earnings (60819)
Employer resources (136)
Events (88683)
Executive appointments (579)
FDA (15252)
Funding (600)
Gene therapy (268)
GLP-1 (679)
Government (4209)
Healthcare (17229)
Infectious disease (2657)
Inflammatory bowel disease (130)
Interviews (521)
IPO (14221)
Job creations (2755)
Job search strategy (1681)
Layoffs (433)
Legal (6050)
Lung cancer (264)
Manufacturing (220)
Medical device (11051)
Medtech (11055)
Mergers & acquisitions (16473)
Metabolic disorders (567)
Neuroscience (1812)
NextGen: Class of 2025 (5965)
Non-profit (4118)
Northern California (1928)
Obesity (311)
Opinion (222)
Patents (160)
People (53804)
Phase I (19830)
Phase II (27923)
Phase III (20767)
Pipeline (717)
Postmarket research (2390)
Preclinical (8335)
Radiopharmaceuticals (251)
Rare diseases (343)
Real estate (4495)
Regulatory (19983)
Research institute (2270)
Resumes & cover letters (359)
Southern California (1726)
Startups (3176)
United States (17060)
Vaccines (589)
Weight loss (224)
Date
Today (82)
Last 7 days (544)
Last 30 days (2474)
Last 365 days (32978)
2025 (4200)
2024 (33634)
2023 (37498)
2022 (48412)
2021 (52024)
2020 (50008)
2019 (42544)
2018 (32072)
2017 (29660)
2016 (28193)
2015 (32972)
2014 (25387)
2013 (20574)
2012 (21784)
2011 (22690)
2010 (20430)
Location
Africa (740)
Arizona (153)
Asia (36084)
Australia (7177)
California (4470)
Canada (1642)
China (375)
Colorado (202)
Connecticut (201)
Europe (80894)
Florida (635)
Georgia (144)
Illinois (413)
Indiana (230)
Maryland (705)
Massachusetts (3332)
Michigan (184)
Minnesota (294)
New Jersey (1274)
New York (1275)
North Carolina (793)
Northern California (1928)
Ohio (152)
Pennsylvania (983)
South America (1013)
Southern California (1726)
Texas (631)
Utah (138)
Washington State (434)
593,294 Results for "aquestive therapeutics formerly known as monosolrx".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Press Releases
Aquestive Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Conference
February 4, 2025
·
3 min read
Press Releases
Aquestive Therapeutics Provides Business Update and Outlines Key 2025 Objectives
January 14, 2025
·
19 min read
Press Releases
Aquestive Therapeutics to Present New Findings on Anaphylm™ (Epinephrine Sublingual Film) at the 2025 AAAAI Annual Meeting
February 12, 2025
·
10 min read
Pharm Country
Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism
Aquestive Therapeutics, Inc. announced that the Aquestive management team will participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism and host investor meetings on July 9, 2024.
June 27, 2024
·
2 min read
Business
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive
Aquestive Therapeutics, Inc. today announced the appointment of Abigail Jenkins to the Company’s Board of Directors, effective April 1, 2024.
April 1, 2024
·
6 min read
Business
Aquestive Therapeutics Announces Executive Appointments and Builds Commercial Capabilities
Aquestive Therapeutics, Inc. today announced it has strengthened its leadership team with three executive appointments ahead of the anticipated launch of Anaphylm™.
June 3, 2024
·
8 min read
Breast cancer
AstraZeneca, Daiichi Sankyo’s ADC Wins First Approval Despite Mixed Data
Datroway, formerly known as Dato-DXd, significantly improved median progression-free survival in a Phase III study but failed to do so for overall survival.
January 21, 2025
·
2 min read
·
Tristan Manalac
Deals
Aquestive Therapeutics Announces Closing of Underwritten Public Offering of Common Stock
Aquestive Therapeutics, Inc. today announced the closing of its previously announced underwritten public offering of 16,666,667 shares of its common stock at the public offering price of $4.50 per share.
March 25, 2024
·
2 min read
Press Releases
Aquestive Therapeutics to Report Fourth Quarter 2024 Financial Results and Recent Business Highlights on March 5 and Host Conference Call on March 6 at 8:00 a.m. ET
February 20, 2025
·
3 min read
1 of 59,330
Next
